DGR n. 664 del 20/06/2011
DGR n. 664 del 20/06/2011
DGR n. 664 del 20/06/2011
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Supplemento ordinario n. 3 al «Bollettino Ufficiale» - serie generale - n. 32 <strong>del</strong> 27 luglio <strong>20</strong>11 19<br />
Lineevincolantirelativeaipercorsiassistenzialieriabilitativi<strong>del</strong>lapersonaconsclerosilateraleamiotrofica(PSLA)<br />
13 Bibliografia essenziale<br />
<br />
BelloHaas,V.D.,J.M.Florence,etal.(<strong>20</strong>07)."Arandomizedcontrolledtrialofresistance<br />
exerciseinindividualswithALS."Neurology68(23):<strong>20</strong>037.<br />
Gordon,P.H.,D.H.Moore,etal.(<strong>20</strong>07)."Efficacyofminocyclineinpatientswith<br />
amyotrophiclateralsclerosis:aphaseIIIrandomisedtrial."LancetNeurol6(12):104553.<br />
Miller,R.G.,J.D.Mitchell,etal.(<strong>20</strong>07)."Riluzoleforamyotrophiclateralsclerosis<br />
(ALS)/motorneurondisease(MND)."CochraneDatabaseSystRev(1):CD001447.<br />
MillerR.G.,J.A.Rosenberg,etal.(1999)."Practiceparameter:thecareofthepatient<br />
withamyotrophiclateralsclerosis(anevidencebasedreview):reportoftheQuality<br />
StandardsSubcommitteeoftheAmericanAcademyofNeurology:ALSPracticeParameters<br />
TaskForce."Neurology52(7):131123.<br />
MillerR.G.,JacksonC.E.,etal.(<strong>20</strong>09)«Practiceparameterupdate:Thecareofthe<br />
patientwithamyotrophiclateralsclerosis:Drug,nutritionalandrespiratorytherapies(an<br />
evidencebasedreview):ReportoftheQualityStandardsSubcommiteeoftheAmerican<br />
AcademyofNeurology”Neurology73:12181226<br />
MillerR.G.,JacksonC.E.,etal.(<strong>20</strong>09)«Practiceparameterupdate:Thecareofthe<br />
patientwithamyotrophiclateralsclerosis:Multidisciplinarycare,symptommanagement<br />
andcognitive/behavioralimpairment(anevidencebasedreview):ReportoftheQuality<br />
StandardsSubcommiteeoftheAmericanAcademyofNeurology”Neurology73:1227<br />
1233<br />
SorensonE.J.,WindbankA.J.,eal.(<strong>20</strong>08)“SubcutaneousIGF1isnotbeneficialin2years<br />
ALStrial”Neurology71:17701775<br />
The_EFNS_Task_Force_on_Diagnosis_and_Management_of_Amyotrophic_Lateral_Scler<br />
osis(<strong>20</strong>05)."EFNStaskforceonmanagementofamyotrophiclateralsclerosis:gui<strong>del</strong>ines<br />
fordiagnosingandclinicalcareofpatientsandrelatives."EuropeanJournalofNeurology<br />
12:921938.<br />
Traynor,B.J.,L.Bruijn,etal.(<strong>20</strong><strong>06</strong>)."NeuroprotectiveagentsforclinicaltrialsinALS:a<br />
systematicassessment."Neurology67(1):<strong>20</strong>7.<br />
Zhang,W.,M.Narayanan,etal.(<strong>20</strong>03)."Additiveneuroprotectiveeffectsofminocycline<br />
withcreatineinamousemo<strong>del</strong>ofALS."AnnNeurol53(2):26770.<br />
15
Change language